StonvexLoading…
StonvexStonvexStonvexCore line items from ASPN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $271.10M | $452.70M | $238.72M | $180.36M |
Operating Income | $-378.23M | $54.53M | $-49.20M | $-79.25M |
Net Income | $-389.55M | $13.38M | $-45.81M | $-82.74M |
EPS (Diluted) | $-4.73 | $0.17 | $-0.66 | $-2.10 |
Total Assets | $406.68M | $895.14M | $703.05M | $643.42M |
Total Liabilities | $171.16M | $280.44M | $214.99M | $195.98M |
Cash & Equivalents | $156.86M | $220.88M | $139.72M | $281.33M |
Free Cash Flow OCF − CapEx | $-4.58M | $-40.71M | $-218.07M | $-272.37M |
Shares Outstanding | 82.71M | 82.04M | 76.50M | 69.99M |